SCHEMBL5206579

SCHEMBL5206579

COc1ccc(C(=O)C(C(=O)c2ccc(C(C)(C)C)cc2)C(=C(C(=O)O)c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
ALDH1A1 P00352 5/20 0.49
LMNA P02545 4/20 0.49
TDP1 Q9NUW8 3/20 0.49
ALOX15 P16050 1/20 0.49
APEX1 P27695 1/20 0.49
MAPK1 P28482 1/20 0.49
RECQL P46063 1/20 0.49
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
POLB P06746 2/20 0.44
EPHX2 P34913 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
KDM4E B2RXH2 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7162385 0.82 MAPT (0.60) MAPTALDH1A1LMNATDP1ALOX15
SCHEMBL2065160 0.75 MAPT (0.52) MAPTALDH1A1LMNATDP1ALOX15
SCHEMBL9353462 0.74 MAPT (0.66) MAPTALDH1A1LMNATDP1ALOX15
SCHEMBL7733638 0.74 MAPT (0.66) MAPTALDH1A1LMNATDP1ALOX15
Avobenzone SCHEMBL5680371 0.73 TDP1 (0.88) MAPTALDH1A1LMNATDP1ALOX15
Avobenzone SCHEMBL19717690 0.73 ALDH1A1 (0.71) MAPTALDH1A1LMNATDP1ALOX15
SCHEMBL4411275 0.71 MAPT (0.53) MAPTALDH1A1LMNATDP1ALOX15
SCHEMBL324099 0.71 CES2 (0.61) MAPTALDH1A1LMNAL3MBTL1CES2
SCHEMBL28576599 0.71 MAPT (0.54) MAPTALDH1A1LMNATDP1ALOX15
SCHEMBL7100665 0.71 ALDH1A1 (0.63) MAPTALDH1A1LMNATDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1796659-A2 SILVER DIHYDROGEN CITRATE COMPOSITIONS Pure Bioscience (US) 2007-06-20 EP disclosed
US-20060115440-A1 Silver dihydrogen citrate compositions PURE BIOSCIENCE 2006-06-01 US disclosed
WO-2006029213-A2 SILVER DIHYDROGEN CITRATE COMPOSITIONS PURE BIOSCIENCE (US) 2006-03-16 WO disclosed
US-20060051430-A1 Silver dihydrogen citrate compositions PURE BIOSCIENCE 2006-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060051430-A1 Silver dihydrogen citrate compositions IDH1, DSG1, SUCLG1 MAPT 984/4885ALDH1A1 1006/4885LMNA 4761/4885
US-20060115440-A1 Silver dihydrogen citrate compositions IDH1, DSG1, SUCLG1 MAPT 984/4885ALDH1A1 1006/4885LMNA 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.